Novel SPG 11 mutations in hereditary spastic paraplegia with thin corpus callosum in a Chinese family

3Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Background: Hereditary spastic paraplegia (HSP) is a neurodegenerative disease that is characterized by progressive weakness and spasticity of the lower extremities; HSP can present as complicated forms with additional neurological signs. More than 70 disease loci have been described with different modes of inheritance. Methods: In this study, nine subjects from a Chinese family that included two individuals affected by HSP were examined through detailed clinical evaluations, physical examinations, and genetic tests. Targeted exome capture technology was used to identify gene mutations. Results: Two novel compound heterozygous mutations in the SPG 11 gene were identified, c.4001-4002insATAAC and c.4057C>G. The c.4001-4002insATAAC mutation leads to a reading frame shift during transcription, resulting in premature termination of the protein product. The missense mutation c.4057C>G (p.H1353D) is located in a highly conserved domain and is predicted to be a damaging substitution. Conclusions: Based on the results described here, we propose that these novel compound heterozygous mutations in SPG 11 are the genetic cause of autosomal recessive HSP in this Chinese family.

Cite

CITATION STYLE

APA

Tian, X., Wang, M., Zhang, K., & Zhang, X. (2016). Novel SPG 11 mutations in hereditary spastic paraplegia with thin corpus callosum in a Chinese family. Canadian Journal of Neurological Sciences, 43(6), 833–840. https://doi.org/10.1017/cjn.2016.17

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free